CanSino vaccine: 90.07% efficacy in serious diseases
CanSino Biologics Inc.‘s vaccine (Ad5-nCoV) is 90.07% effective in preventing serious illness 28 days after single-dose Covid-19 vaccination. Likewise, the percentage increases to 95.47% in
CanSino Biologics Inc.‘s vaccine (Ad5-nCoV) is 90.07% effective in preventing serious illness 28 days after single-dose Covid-19 vaccination. Likewise, the percentage increases to 95.47% in
La vacuna de CanSino Biologics Inc. (Ad5-nCoV) tiene una eficacia de 90.07% en la prevención de enfermedades graves 28 días después de la vacunación de
Agnico Eagle Mines Limited reported that it plans to increase its capital expenditures 5.8% in 2021, to $ 803 million. Headquartered in Toronto, Canada, the
Agnico Eagle Mines Limited informó que planea incrementar 5.8% sus gastos de capital en 2021, a 803 millones de dólares. Con sede en Toronto, Canadá,
The United Nations Conference on Trade and Development (UNCTAD) predicted that GDP in the euro area would reach 4% growth in 2021. As a base
La Conferencia de Naciones Unidas sobre Comercio y Desarrollo (UNCTAD) pronosticó que el PIB en la zona del euro alcanzaría un crecimiento de 4% en
info@opportimes.com